An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS von Morrow, D.A., Antman, E.M., Snapinn, S.M., McCabe, C.H., Theroux, P., Braunwald, E.

Volltext

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy von Brenner, Barry M, Cooper, Mark E, de Zeeuw, Dick, Keane, William F, Mitch, William E, Parving, Hans-Henrik, Remuzzi, Giuseppe, Snapinn, Steven M, Zhang, Zhonxin, Shahinfar, Shahnaz

Volltext

Does Albuminuria Predict Cardiovascular Outcomes on Treatment With Losartan Versus Atenolol in Patients With Diabetes, Hypertension, and Left Ventricular Hypertrophy?: The LIFE stu... von Ibsen, Hans, Olsen, Michael H, Wachtell, Kristian, Borch-Johnsen, Knut, Lindholm, Lars H, Mogensen, Carl E, Dahlöf, Björn, Snapinn, Steven M, Wan, Ying, Lyle, Paulette A

Volltext

A discriminant analysis extension to mixed models von Tomasko, Lisa, Helms, Ronald W., Snapinn, Steven M.

Volltext

Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies von Carr, Albert A., Kowey, Peter R., Devereux, Richard B., Brenner, Barry M., Dahlöf, Björn, Ibsen, Hans, Lindholm, Lars H., Lyle, Paulette A., Snapinn, Steven M., Zhang, Zhongxin, Edelman, Jonathan M., Shahinfar, Shahnaz

Volltext

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy : The losartan interven... von OKIN, Peter M, DEVEREUX, Richard B, DAHLOF, Björn, GERDTS, Eva, SNAPINN, Steven M, HARRIS, Katherine E, JERN, Sverker, KJELDSEN, Sverre E, JULIUS, Stevo, EDELMAN, Jonathan M, LINDHOLM, Lars H

Volltext

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: Angiographic results from the PRI... von ZHAO, X.-Q, THEROUX, P, SNAPINN, S. M, SAX, F. L

Volltext

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study von Kizer, Jorge R, Dahlöf, Björn, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Wachtell, Kristian, Edelman, Jonathan M, Snapinn, Steven M, Harris, Katherine E, Devereux, Richard B

Volltext

Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy von Fyhrquist, Frej, Dahlöf, Björn, Devereux, Richard B, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Hille, Darcy A, Lyle, Paulette A, Edelman, Jonathan M, Snapinn, Steven M, Wedel, Hans

Volltext

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in h... von Fossum, Eigil, Moan, Andreas, Kjeldsen, Sverre E, Devereux, Richard B, Julius, Stevo, Snapinn, Steven M, Edelman, Jonathan M, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Dahlöf, Björn

Volltext

Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Contr... von Blazing, Michael A, de Lemos, James A, White, Harvey D, Fox, Keith A. A, Verheugt, Freek W. A, Ardissino, Diego, DiBattiste, Peter M, Palmisano, Joanne, Bilheimer, David W, Snapinn, Steven M, Ramsey, Karen E, Gardner, Laura H, Hasselblad, Vic, Pfeffer, Marc A, Lewis, Eldrin F, Braunwald, Eugene, Califf, Robert M

Volltext

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study von Kjeldsen, Sverre E., Devereux, Richard B., Hille, Darcy A., Lyle, Paulette A., Dahlöf, Björn, Julius, Stevo, Edelman, Jonathan M., Snapinn, Steven M., de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Lederballe-Pedersen, Ole, Lindholm, Lars H., Nieminen, Markku S., Omvik, Per, Oparil, Suzanne, Wedel, Hans

Volltext

Noninferiority trials von Snapinn, Steven M

Volltext

Estimation of Error Rates in Discriminant Analysis with Selection of Variables von Snapinn, Steven M., Knoke, James D.

Volltext

Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving β-blockade after myocardial infarction von Bonarjee, Vernon V.S., Carstensen, Steen, Caidahl, Kenneth, Nilsen, Dennis W.T., Edner, Magnus, Lindvall, Kaj, Snapinn, Steven M., Berning, Jens

Volltext

Survival Analysis with Uncertain Endpoints von Snapinn, Steven M.

Volltext

Tests of Significance Using Regression Models for Ordered Categorical Data von Snapinn, Steven M., Small, Robert D.

Volltext

Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator von Snapinn, Steven M, Jiang, Qi, Iglewicz, Boris

Volltext

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study von Keane, William F., Brenner, Barry M., de Zeeuw, Dick, Grunfeld, Jean-Pierre, McGill, Janet, Mitch, William E., Ribeiro, Artur B., Shahinfar, Shahnaz, Simpson, Roger L., Snapinn, Steven M., Toto, Robert, RENAAL Study Investigators

Volltext

Power considerations when a continuous outcome variable is dichotomized von Deyi, Ben A., Kosinski, Andrzej S., Snapinn, Steve M.

Volltext